Announcements Trials
Browse Landscape

Phase

Phase 3 5

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Conditions

Colitis, Ulcerative 5

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × etrolizumab × Clear all
NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed
397 enrolled 32 charts

Colitis, Ulcerative

NCT02165215 2021-08-19

LAUREL

Hoffmann-La Roche

Phase 3 Completed
359 enrolled 34 charts

Colitis, Ulcerative

NCT02100696 2021-08-13

HICKORY

Hoffmann-La Roche

Phase 3 Completed
609 enrolled 52 charts

Colitis, Ulcerative

NCT02163759 2021-07-23

HIBISCUS I

Hoffmann-La Roche

Phase 3 Completed
358 enrolled 42 charts

Colitis, Ulcerative

NCT02171429 2021-07-23

HIBISCUS II

Hoffmann-La Roche

Phase 3 Completed
358 enrolled 38 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡